Trials / Completed
CompletedNCT01471405
One Year Follow-up of Study 2-79-52030-207 (PRIMARYS) in Acromegalic Patients With Macroadenoma
Retrospective Non-interventional Study Evaluating Treatment Adaption During a One Year Follow-up After Completion of the 2-79-52030-207 Study in a Group of Acromegalic Patients With Macroadenoma Who Received 12 Injections of Lanreotide Autogel® 120 mg
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 54 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This non-interventional retrospective study aims to describe the therapeutic procedures and modalities received by patients and the correlation to hormone status, during a one year follow up from completion of the 2-79-52030-207 study.
Conditions
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2013-05-01
- Completion
- 2013-08-01
- First posted
- 2011-11-15
- Last updated
- 2019-01-11
Locations
18 sites across 6 countries: Czechia, France, Germany, Italy, Turkey (Türkiye), United Kingdom
Source: ClinicalTrials.gov record NCT01471405. Inclusion in this directory is not an endorsement.